199 related articles for article (PubMed ID: 29031063)
1. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
[TBL] [Abstract][Full Text] [Related]
2. New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPARγ modulators.
Bar M; Skóra B; Tabęcka-Łonczyńska A; Holota S; Khyluk D; Roman O; Lesyk R; Szychowski KA
Bioorg Chem; 2022 Nov; 128():106075. PubMed ID: 35952447
[TBL] [Abstract][Full Text] [Related]
3. 4-Thiazolidinone-based derivatives do not affect differentiation of mouse embryo fibroblasts (3T3-L1 cell line) into adipocytes.
Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Tobiasz J; Lesyk RB; Gmiński J
Chem Biol Interact; 2021 Aug; 345():109538. PubMed ID: 34097888
[TBL] [Abstract][Full Text] [Related]
4. 4-thiazolidinone-based derivatives rosiglitazone and pioglitazone affect the expression of antioxidant enzymes in different human cell lines.
Szychowski KA; Skóra B; Kryshchyshyn-Dylevych A; Kaminskyy D; Khyluk D; Lesyk R
Biomed Pharmacother; 2021 Jul; 139():111684. PubMed ID: 34243632
[TBL] [Abstract][Full Text] [Related]
5. Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells.
Finiuk N; Kaleniuk E; Holota S; Stoika R; Lesyk R; Szychowski KA
Bioorg Med Chem; 2023 Sep; 92():117442. PubMed ID: 37579525
[TBL] [Abstract][Full Text] [Related]
6. Study of antineoplastic action of novel isomeric derivatives of 4-thiazolidinone.
Chumak VV; Fil MR; Panchuk RR; Zimenkovsky BS; Havrylyuk DY; Lesyk RB; Stoika RS
Ukr Biochem J; 2014; 86(6):96-105. PubMed ID: 25816610
[TBL] [Abstract][Full Text] [Related]
7. [Development of a cell-based peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of triterpenoids isolate from Alismatis Rhizoma].
Li XY; Wang XH; Huang XQ; Wu TT; Xu W; Wu SS
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4015-4022. PubMed ID: 28929690
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel 4-thiazolidinone derivatives with promising anti-breast cancer activity: Synthesis, characterization, in vitro and in vivo results.
Tahmasvand R; Bayat P; Vahdaniparast SM; Dehghani S; Kooshafar Z; Khaleghi S; Almasirad A; Salimi M
Bioorg Chem; 2020 Nov; 104():104276. PubMed ID: 32992280
[TBL] [Abstract][Full Text] [Related]
10. Study of novel anticancer 4-thiazolidinone derivatives.
Szychowski KA; Leja ML; Kaminskyy DV; Binduga UE; Pinyazhko OR; Lesyk RB; Gmiński J
Chem Biol Interact; 2017 Jan; 262():46-56. PubMed ID: 27965178
[TBL] [Abstract][Full Text] [Related]
11. The interaction of 4-thiazolidinone derivatives containing indolin-2-one moiety with P-glycoprotein studied using K562 cell lines.
Wang F; Liu Z; Wang J; Tao J; Gong P; Bao X; Zhao Y; Wang Y
Eur J Med Chem; 2015 Aug; 101():126-32. PubMed ID: 26123642
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives.
Skóra B; Lewińska A; Kryshchyshyn-Dylevych A; Kaminskyy D; Lesyk R; Szychowski KA
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164157
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
Xiong X; Ye Y; Fu L; Dai B; Liu J; Jia J; Tang J; Li L; Wang L; Shen J; Mei C
Invest New Drugs; 2009 Jun; 27(3):223-32. PubMed ID: 18704263
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and tumor inhibitory studies of 2,3 disubstituted 4-thiazolidinone derivatives.
Sharath Kumar KS; Hanumappa A; Vetrivel M; Hegde M; Girish YR; Byregowda TR; Rao S; Raghavan SC; Rangappa KS
Bioorg Med Chem Lett; 2015 Sep; 25(17):3616-20. PubMed ID: 26152430
[TBL] [Abstract][Full Text] [Related]
15. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.
Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770
[TBL] [Abstract][Full Text] [Related]
16. HL005--a new selective PPARγ antagonist specifically inhibits the proliferation of MCF-7.
Lu W; Che P; Zhang Y; Li H; Zou S; Zhu J; Deng J; Shen X; Jiang H; Li J; Huang J
J Steroid Biochem Mol Biol; 2011 Apr; 124(3-5):112-20. PubMed ID: 21296151
[TBL] [Abstract][Full Text] [Related]
17. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.
Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G
J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681
[TBL] [Abstract][Full Text] [Related]
18. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
[TBL] [Abstract][Full Text] [Related]
19. A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells.
Onen-Bayram FE; Durmaz I; Scherman D; Herscovici J; Cetin-Atalay R
Bioorg Med Chem; 2012 Sep; 20(17):5094-102. PubMed ID: 22867707
[TBL] [Abstract][Full Text] [Related]
20. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]